Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRADO: Dose Study of Tranexamic Acid in Total Hip Replacement
NCT03822793Phase 2Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Dec 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tranexamic acid in postoperative hemorrhage (5 arms), sponsored by CHU Saint-Etienne. Primary endpoint: haemoglobin decrease in the perioperative period. Started Dec 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT03822793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03822793.